GlassScriptPhysician profile
Daniel J Savitt
NPI 1992149603
$6,895.67
in general payments reported to CMS, 2019-2025
12 companies · $21.09 in 2025
The $21.09 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,650 · 2020: $36.41 · 2021: $42.38 · 2022: $41.78 · 2023: $104 · 2025: $21.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $124.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $6,403.16 | 2019 | |
| Boston Scientific Corporation | $160.64 | 2019 | |
| Argenx US, INC. | $103.72 | 2023 | Vyvgart |
| Acorda Therapeutics, INC | $60.43 | 2019 | |
| Biogen, INC. | $52.54 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $31.54 | 2021-2022 | |
| Medtronic, INC. | $22.43 | 2022 | |
| Mdd US Operations, LLC | $21.09 | 2025 | |
| Abbott Laboratories | $14.06 | 2021 | |
| Merz North America, INC. | $13.60 | 2019 | |
| Akcea Therapeutics, INC. | $12.46 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Savitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.